Diagnostics Startups Take On Growing Threat of Antibiotic-Resistant Bugs
24 January 2020
A new breed of diagnostic companies is rolling out technologies to tackle a growing and deadly health-care problem: antibiotic-resistant bugs.
More than 35,000 Americans die annually from drug-resistant bacterial and fungal infections, according to a November report from the Centers for Disease Control and Prevention. And 270,000 people die annually from sepsis, an overwhelming response to an infection, according to the National Institute of General Medical Sciences.
Further reading: WSJ PRO Private Equity
Author(s): Brian Gormley
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
